GW&K Investment Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$0 Hold
46
﹤0.01% 1034
2025
Q4
$0 Hold
46
﹤0.01% 1015
2025
Q3
$0 Hold
46
﹤0.01% 1005
2025
Q2
$0 Hold
46
﹤0.01% 1019
2025
Q1
$1K Hold
46
﹤0.01% 998
2024
Q4
$1K Hold
46
﹤0.01% 962
2024
Q3
$1K Hold
46
﹤0.01% 948
2024
Q2
$1K Hold
46
﹤0.01% 922
2024
Q1
$1K Hold
46
﹤0.01% 906
2023
Q4
$1K Sell
46
-425
-90% -$5.78K ﹤0.01% 911
2023
Q3
$8K Buy
471
+321
+214% +$6.69K ﹤0.01% 683
2023
Q2
$3K Buy
150
+103
+219% +$2.24K ﹤0.01% 825
2023
Q1
$1K Buy
47
+34
+262% +$913 ﹤0.01% 455
2022
Q4
$0 Buy
+13
New +$332 ﹤0.01% 482
2022
Q2
Sell
-113
Closed -$4K 840
2022
Q1
$4K Buy
+113
New +$3.86K ﹤0.01% 591

Other funds holding OGN

GW&K Investment Management's OGN Position: Q1 2026 in Review

GW&K Investment Management held its Organon & Co (OGN) position steady in Q1 2026 at 46 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1034.

GW&K Investment Management first reported a position in OGN in Q1 2022 and has held it in 15 quarters since. The position peaked at $8K in Q3 2023. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • GW&K Investment Management held 46 shares of Organon & Co worth $0 as of Q1 2026.
  • GW&K Investment Management left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of GW&K Investment Management's portfolio in Q1 2026, its #1034 holding.
  • GW&K Investment Management first reported a position in Organon & Co in Q1 2022 and has held it in 15 quarters since.
  • GW&K Investment Management's Organon & Co position peaked at $8K in Q3 2023.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.